C12N 2795/10032
Use of virus as therapeutic agent, other than vaccine
Official title: Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
C12N2795/10032 (Use of virus as therapeutic agent, other than vaccine) appears on 12 US grants and 49 published applications in this corpus.
Search patents in C12N- Granted patents
- 12
- Published applications
- 49
- Assignees
- 38
- Inventors
- 136
- Latest grant
- 28 Apr 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2004 | 0 | 1 |
| 2005 | 0 | 0 |
| 2006 | 0 | 1 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 1 | 1 |
| 2011 | 0 | 0 |
| 2012 | 0 | 1 |
| 2013 | 0 | 0 |
| 2014 | 0 | 1 |
| 2015 | 1 | 0 |
| 2016 | 1 | 1 |
| 2017 | 1 | 0 |
| 2018 | 0 | 1 |
| 2019 | 0 | 1 |
| 2020 | 1 | 1 |
| 2021 | 1 | 4 |
| 2022 | 2 | 9 |
| 2023 | 0 | 4 |
| 2024 | 3 | 7 |
| 2025 | 0 | 11 |
| 2026 | 1 | 5 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Microencapsulation of bacteriophages and related products28 Apr 2026US 12,611,435 B2Precisio Biotix Therapeutics, Inc.
- Method for purification of bacteriophage particles11 Jun 2024US 12,006,517 B2Adaptive Phage Therapeutics, Inc.
- Aggregation induced emission-bacteriophage bioconjugates2 Apr 2024US 11,944,682 B2The Hong Kong University of Science and Technologyy
- Host bacterium specific nanoparticle26 Mar 2024US 11,939,592 B2National University Corporation Tokai National Higher Education and Research System
- Microencapsulation of bacteriophages and related products16 Aug 2022US 11,413,319 B2Phagelux (Canada) Inc.
- Bacteriophage27 Aug 2026US 2026/0250642 A1Arrowsmith Inc.
- Bacteriophages for the control of bacterial spot and bacterial speck disease6 Aug 2026US 2026/0223860 A1
- Staphylococcus phage compositions and cocktails thereof7 May 2026US 2026/0124259 A1Locus Biosciences, Inc.
- Bacteriophage compositions and methods for treatment of bacterial infections23 Apr 2026US 2026/0108570 A1The University of Chicago
- Mycobacteriophage compositions and related methods23 Apr 2026US 2026/0108571 A1Oregon State University
Most cited
By later US patents
- Bacteriophage for the treatment of bacterial biofilms12US 7,758,856 B2Biocontrol Limited · 2010
- Antibacterial phage, phage peptides and methods of use thereof2US 9,134,312 B2Technophage, InvestigaçãO E Desenvolvimento Em Biotecnologia, SA · 2015
- Microencapsulation of bacteriophages and related products1US 11,413,319 B2Phagelux (Canada) Inc. · 2022
- Antibacterial phage, phage peptides and methods of use thereof1US 9,682,110 B2Technophage,Investigacao E Desenvolvimento Em Biotechnologia, SA · 2017